- Record: found
- Abstract: not found
- Article: not found
TAS-116, a novel, orally bioavailable highly potent HSP90a/ß selective inhibitor demonstrates favorable tissue distribution properties which lead to minimized ocular toxicity
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.